The Role of P38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease

Overview

Journal J Signal Transduct

Date 2012 Jul 14

PMID 22792454

Citations 113

Authors

Sonia A L Correa

Katherine L Eales

Affiliations

Soon will be listed here.

Abstract

A significant amount of evidence suggests that the p38-mitogen-activated protein kinase (MAPK) signalling cascade plays a crucial role in synaptic plasticity and in neurodegenerative diseases. In this review we will discuss the cellular localisation and activation of p38 MAPK and the recent advances on the molecular and cellular mechanisms of its substrates: MAPKAPK 2 (MK2) and tau protein. In particular we will focus our attention on the understanding of the p38 MAPK-MK2 and p38 MAPK-tau activation axis in controlling neuroinflammation, actin remodelling and tau hyperphosphorylation, processes that are thought to be involved in normal ageing as well as in neurodegenerative diseases. We will also give some insight into how elucidating the precise role of p38 MAPK-MK2 and p38 MAPK-tau signalling cascades may help to identify novel therapeutic targets to slow down the symptoms observed in neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Citing Articles

Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection-A Systematic Review.

Azizan Z, Bazrgar M, Bazgir N, Moini S, Ghaseminejad-Kermani S, Safa K CNS Neurosci Ther. 2025; 31(2):e70269.

PMID: 39957678 PMC: 11831194. DOI: 10.1111/cns.70269.

A Network Pharmacology Study and Experimental Validation to Identify the Potential Mechanism of Heparan Sulfate on Alzheimer's Disease-Related Neuroinflammation.

Kim D, Kweon B, Oh J, Lim Y, Noh G, Yu J Biomedicines. 2025; 13(1).

PMID: 39857687 PMC: 11761859. DOI: 10.3390/biomedicines13010103.

Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.

Aikio M, Odeh H, Wobst H, Lee B, Chan U, Mauna J Cell Rep. 2025; 44(1):115205.

PMID: 39817908 PMC: 11831926. DOI: 10.1016/j.celrep.2024.115205.

Oxidative/Nitrosative Stress and Brain Involvement in Sepsis: A Relationship Supported by Immunohistochemistry.

Bertozzi G, Ferrara M, Calvano M, Pascale N, Di Fazio A Medicina (Kaunas). 2025; 60(12.

PMID: 39768830 PMC: 11678000. DOI: 10.3390/medicina60121949.

Depression like-behavior and memory loss induced by methylglyoxal is associated with tryptophan depletion and oxidative stress: a new in vivo model of neurodegeneration.

Md Samsuzzaman , Hong S, Lee J, Park H, Chang K, Kim H Biol Res. 2024; 57(1):87.

PMID: 39574138 PMC: 11580208. DOI: 10.1186/s40659-024-00572-4.

References

Collingridge G, Peineau S, Howland J, Wang Y . Long-term depression in the CNS. Nat Rev Neurosci. 2010; 11(7):459-73. DOI: 10.1038/nrn2867. View

Beardmore V, Hinton H, Eftychi C, Apostolaki M, Armaka M, Darragh J . Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol. 2005; 25(23):10454-64. PMC: 1291241. DOI: 10.1128/MCB.25.23.10454-10464.2005. View

Shigematsu K, McGeer P, Walker D, Ishii T, McGeer E . Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J Neurosci Res. 1992; 31(3):443-53. DOI: 10.1002/jnr.490310306. View

Kakimura J, Kitamura Y, Takata K, Umeki M, Suzuki S, Shibagaki K . Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 2002; 16(6):601-3. DOI: 10.1096/fj.01-0530fje. View

Farias G, Munoz J, Garrido J, Maccioni R . Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies. J Cell Biochem. 2002; 85(2):315-24. DOI: 10.1002/jcb.10133. View

Cookson M . alpha-Synuclein and neuronal cell death. Mol Neurodegener. 2009; 4:9. PMC: 2646729. DOI: 10.1186/1750-1326-4-9. View

Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K . Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys. 1998; 357(2):299-309. DOI: 10.1006/abbi.1998.0813. View

Hartzler A, Zhu X, Siedlak S, Castellani R, Avila J, Perry G . The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau. Neurobiol Aging. 2002; 23(5):855-9. DOI: 10.1016/s0197-4580(02)00029-5. View

He H, Wang X, Pan R, Wang D, Liu M, He R . The proline-rich domain of tau plays a role in interactions with actin. BMC Cell Biol. 2009; 10:81. PMC: 2784441. DOI: 10.1186/1471-2121-10-81. View

10.

Munoz L, Ammit A . Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology. 2009; 58(3):561-8. DOI: 10.1016/j.neuropharm.2009.11.010. View

11.

Hoover B, Reed M, Su J, Penrod R, Kotilinek L, Grant M . Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010; 68(6):1067-81. PMC: 3026458. DOI: 10.1016/j.neuron.2010.11.030. View

12.

Lesage S, Brice A . Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009; 18(R1):R48-59. DOI: 10.1093/hmg/ddp012. View

13.

Dotti C, Banker G, Binder L . The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience. 1987; 23(1):121-30. DOI: 10.1016/0306-4522(87)90276-4. View

14.

Hashimoto Y, Niikura T, Chiba T, Tsukamoto E, Kadowaki H, Nishitoh H . The cytoplasmic domain of Alzheimer's amyloid-beta protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. J Pharmacol Exp Ther. 2003; 306(3):889-902. DOI: 10.1124/jpet.103.051383. View

15.

Moraga D, Nunez P, Garrido J, Maccioni R . A tau fragment containing a repetitive sequence induces bundling of actin filaments. J Neurochem. 1993; 61(3):979-86. DOI: 10.1111/j.1471-4159.1993.tb03611.x. View

16.

Thomas T, Timmer M, Cesnulevicius K, Hitti E, Kotlyarov A, Gaestel M . MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson's disease. J Neurochem. 2008; 105(5):2039-52. DOI: 10.1111/j.1471-4159.2008.05310.x. View

17.

Ferrer I, Cruz-Sanchez F, Guionnet N, Tunon T . [A study of senile plaques with a combined method in brains of patients suffering from Alzheimer's disease]. Arch Neurobiol (Madr). 1990; 53(6):222-6. View

18.

Shi Y, Gaestel M . In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol Chem. 2002; 383(10):1519-36. DOI: 10.1515/BC.2002.173. View

19.

Bodles A, Barger S . Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging. 2004; 26(1):9-16. DOI: 10.1016/j.neurobiolaging.2004.02.022. View

20.

Skaper S . The brain as a target for inflammatory processes and neuroprotective strategies. Ann N Y Acad Sci. 2007; 1122:23-34. DOI: 10.1196/annals.1403.002. View